QA: Immunogen Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2023_Immunogen_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0000855654, Immunogen Inc

  xvar xval
0 AssetsCurrent 304,121,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,377,000
3 remainder_Assets 40,438,000
4 LiabilitiesCurrent 121,858,000
5 LiabilitiesNoncurrent 47,803,000
6 remainder_Liabilities 23,449,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 475,281,119
9 ResearchAndDevelopmentExpense 226,816,734
10 remainder_Expenses 8,379,872
11 remainder_Revenues 95,728,945
12 remainder_NetIncome 2,532,581
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 348,936,000
1 Liabilities 193,110,000
2 Expenses 710,477,725
3 Revenues 95,728,945
4 StockholdersEquity 155,826,000
5 NetIncome -612,216,199
6 ComprehensiveNetIncome -612,216,199
7 BaseVar 675,392,626
8 EconomicCapitalRatiobeforeLimitedLiability -1.01
9 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time